AMP Capital Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-95,231
| Closed | -$17.3M | – | 964 |
|
|
2021
Q3 | $17.3M | Sell |
95,231
-14,291
| -13% | -$2.79M | 0.1% | 246 |
|
|
2021
Q2 | $22M | Buy |
109,522
+2,075
| +2% | +$434K | 0.11% | 230 |
|
|
2021
Q1 | $23.1M | Sell |
107,447
-6,414
| -6% | -$1.41M | 0.12% | 215 |
|
|
2020
Q4 | $26.5M | Sell |
113,861
-5,134
| -4% | -$1.18M | 0.14% | 170 |
|
|
2020
Q3 | $32.2M | Sell |
118,995
-302
| -0.3% | -$83.3K | 0.19% | 123 |
|
|
2020
Q2 | $34M | Sell |
119,297
-15,781
| -12% | -$4.28M | 0.21% | 115 |
|
|
2020
Q1 | $31.3M | Buy |
135,078
+10,243
| +8% | +$2.35M | 0.23% | 102 |
|
|
2019
Q4 | $27.3M | Buy |
124,835
+36,913
| +42% | +$7.47M | 0.15% | 173 |
|
|
2019
Q3 | $14.7M | Sell |
87,922
-8,757
| -9% | -$1.55M | 0.08% | 268 |
|
|
2019
Q2 | $17.3M | Sell |
96,679
-9,267
| -9% | -$1.62M | 0.1% | 236 |
|
|
2019
Q1 | $19.3M | Sell |
105,946
-5,894
| -5% | -$1.09M | 0.11% | 222 |
|
|
2018
Q4 | $18.1M | Sell |
111,840
-6,016
| -5% | -$1.04M | 0.11% | 208 |
|
|
2018
Q3 | $22.4M | Sell |
117,856
-16,438
| -12% | -$2.93M | 0.12% | 205 |
|
|
2018
Q2 | $22.8M | Sell |
134,294
-23,196
| -15% | -$3.6M | 0.13% | 204 |
|
|
2018
Q1 | $25.1M | Sell |
157,490
-4,682
| -3% | -$765K | 0.14% | 179 |
|
|
2017
Q4 | $24.3M | Buy |
162,172
+32,030
| +25% | +$4.74M | 0.13% | 189 |
|
|
2017
Q3 | $19.8M | Buy |
130,142
+25,378
| +24% | +$3.82M | 0.11% | 210 |
|
|
2017
Q2 | $13.3M | Buy |
104,764
+18,936
| +22% | +$2.28M | 0.08% | 270 |
|
|
2017
Q1 | $9.21M | Buy |
85,828
+15,535
| +22% | +$1.37M | 0.05% | 372 |
|
|
2016
Q4 | $5.23M | Buy |
70,293
+362
| +0.5% | +$29.5K | 0.03% | 508 |
|
|
2016
Q3 | $5.95M | Sell |
69,931
-14,368
| -17% | -$1.36M | 0.04% | 462 |
|
|
2016
Q2 | $7.17M | Sell |
84,299
-15,580
| -16% | -$1.35M | 0.05% | 385 |
|
|
2016
Q1 | $7.83M | Buy |
99,879
+549
| +0.6% | +$49.7K | 0.05% | 376 |
|
|
2015
Q4 | $12.6M | Sell |
99,330
-9,081
| -8% | -$1.1M | 0.09% | 254 |
|
|
2015
Q3 | $10.8M | Sell |
108,411
-13,556
| -11% | -$1.74M | 0.08% | 269 |
|
|
2015
Q2 | $14.9M | Sell |
121,967
-40,564
| -25% | -$5.11M | 0.1% | 233 |
|
|
2015
Q1 | $19.7M | Buy |
162,531
+40,100
| +33% | +$4.8M | 0.12% | 201 |
|
|
2014
Q4 | $14.6M | Sell |
122,431
-1,100
| -0.9% | -$124K | 0.09% | 254 |
|
|
2014
Q3 | $14.1M | Buy |
123,531
+4,957
| +4% | +$472K | 0.09% | 261 |
|
|
2014
Q2 | $11.1M | Sell |
118,574
-88,382
| -43% | -$6.2M | 0.07% | 325 |
|
|
2014
Q1 | $14M | Buy |
206,956
+57,960
| +39% | +$4.59M | 0.09% | 251 |
|
|
2013
Q4 | $11M | Buy |
148,996
+31,574
| +27% | +$2.2M | 0.08% | 317 |
|
|
2013
Q3 | $8.94M | Sell |
117,422
-13,461
| -10% | -$1.07M | 0.07% | 332 |
|
|
2013
Q2 | $10.5M | Buy |
+130,883
| New | +$9.64M | 0.08% | 275 |
|
Other funds holding VRTX
AMP Capital Investors's VRTX Position: Q4 2021 in Review
AMP Capital Investors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 95,231 shares — an estimated $17.3M sold.
AMP Capital Investors first reported a position in VRTX in Q2 2013 and held it in 34 quarters. The position peaked at $34M in Q2 2020. 1,034 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.
- AMP Capital Investors reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 95,231 Vertex Pharmaceuticals shares in Q4 2021, an estimated $17.3M.
- AMP Capital Investors first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Vertex Pharmaceuticals position peaked at $34M in Q2 2020.
- 1,034 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.